Multinational pharmaceutical investment in Asia : implications for Vietnam
| dc.contributor.author | Hoang, Susan Nga | |
| dc.date.accessioned | 2009-06-05T21:16:42Z | |
| dc.date.available | 2009-06-05T21:16:42Z | |
| dc.date.issued | 1999-06 | |
| dc.description | iv, 47 p. A THESIS Presented to the Interdisciplinary Studies Program: International Studies and the Clark Honors College of the University of Oregon in partial fulfillment of the requirements for degree of Bachelor of Arts, 1999. | en_US |
| dc.description.abstract | The pharmaceutical industry is one of the most lucrative industries in the world. The emergence of foreign pharmaceutical companies in Asia is a very hot prospect for both the companies and the countries. Examining Japan's and Singapore's pharmaceutical industries, the two largest in Asia, provides insights into the strengths and weaknesses other countries and foreign companies should consider. Furthermore, comparing these characteristics with Vietnam's will provide insight into how Vietnam can be a contender as a host country to foreign pharmaceutical companies. | en_US |
| dc.identifier.uri | https://hdl.handle.net/1794/9333 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | University of Oregon | en_US |
| dc.relation.ispartofseries | University of Oregon theses, International Studies, Honors College, B.A., 1999; | |
| dc.subject | Pharmaceutical industry -- Singapore | en |
| dc.subject | Pharmaceutical industry -- Japan | en |
| dc.subject | Pharmaceutical industry -- Vietnam | en |
| dc.title | Multinational pharmaceutical investment in Asia : implications for Vietnam | en_US |
| dc.type | Thesis | en_US |